Reox Given £5 Million Boost by U.S. Biotech

Reox, a company spun out of Oxford University by four professors, is believed to have struck a deal with the American biotech Amgen, providing it with £5 million for the exclusive rights to a scientific discovery involving possible cancer and stroke treatments. The Oxford-based company will receive more if the treatments are a success and has said that it will pour the cash into related areas of biological research.

Guardian Unlimited (http://www.guardian.co.uk/business/story/0,3604,1462057,00.html)